Millions of people with asthma use the blue inhaler to help relieve the symptoms when they have an attack but a doctor is now ...
More than one million asthma patients in England have transitioned from traditional blue reliever inhalers to combination inhalers that also treat airway inflammation. The move follows updated NICE ...
For many years, the blue inhaler — medically referred to as a short-acting beta2 agonist or SABA — has been a lifeline for ...
For World Asthma Day, GINA is spotlighting the need for greater access to inhaled corticosteroids for everyone, from adults ...
Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain uncertain ...
The U.S. Food and Drug Administration has approved Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) as a ...
The Food and Drug Administration (FDA) has approved Breztri Aerosphere ® (budesonide/glycopyrrolate/formoterol fumarate; BGF) for the maintenance treatment of asthma in adult and ...
New reliever therapy reduced airway inflammation in adults with asthma using maintenance inhaled corticosteroids. Read more.
The FDA has approved a fixed-dose triple combination therapy for the maintenance treatment of asthma in adults and children aged 12 years and older, according to a press release from manufacturer ...
The FDA approved budesonide/glycopyrrolate/formoterol fumarate (Breztri Aerosphere) in a single inhaler as maintenance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results